In support of its proposed regulatoryframework for Salmonella in raw poultry, USDA-FSIS has notified veterinary biologics manufacturers of its interest in vaccines for serotypes of public health significance.
A recent study suggests that global control measures for Highly Pathogenic Avian Influenza (HPAI) H5N1 infection in poultry and dairy cattle are insufficient. Gaps in control measures exist, including resistance to modern vaccines and surveillance technologies.
At the 2024 Farm Progress Show, U.S. Department of Agriculture (USDA) Secretary Tom Vilsack revealed that the agency is beginning field trials for a vaccine to address the ongoing outbreak of Highly Pathogenic Avian Influenza (HPAI) H5N1—also known as “bird flu”—in cattle.
To encourage the use of Salmonella vaccines for poultry flocks, the U.S. Department of Agriculture’s Food Safety and Inspection Service (USDA’s FSIS) intends to exclude current commercial vaccine subtypes of Salmonella confirmed in FSIS raw poultry samples from the calculation used to categorize establishments under the raw poultry Salmonella performance standards.
Researchers from the Washington University School of Medicine in St. Louis are developing a vaccine for human norovirus, which is the leading cause of foodborne illness worldwide.
